Improving Health and Quality of Life for Rural Older Adults with HIV
This study is looking for older adults (age 50 and up) living with HIV in certain rural areas of the Southern U.S. It aims to improve their health and quality of life. The study is testing two approaches: a "Supportive-Expressive Peer Social Support Group Intervention" and an "Individual Strengths-Based Case Management Intervention." Researchers want to see if these interventions help with viral suppression (keeping the amount of HIV in the body low), taking HIV medications as prescribed (adherence), and overall quality of life. The study is currently recruiting 352 participants.
- Study design
- This interventional study plans to enroll 352 participants. It is testing two different behavioral interventions.
- What's involved
- Participants will either join weekly virtual support group meetings for 8 weeks or have two 60-minute telephone or video-based counseling sessions. Follow-up assessments will occur at 4, 8, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after starting the interventions to measure viral suppression, medication adherence, and quality of life.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jennifer Walsh, PhD · PRINCIPAL_INVESTIGATOR · Center for AIDS Intervention Research, Medical College of Wisconsin
- Andrew Petroll, MD · PRINCIPAL_INVESTIGATOR · Center for AIDS Intervention Research, Medical College of Wisconsin
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Viral Suppression4 and 12 month follow-ups
HIV viral load will be assessed using self-collected dried blood spot (DBS) samples, with samples collecting using HemaSpot devices. Viral suppression will be defined as a measured viral load less than or equal to 839 copies/mL.
- Antiretroviral Treatment Medication Adherence4, 8, and 12 month follow-ups
Recent (past 30 day) antiretroviral treatment adherence will be self-reported using the 3-item Wilson Medication Adherence Scale. The calculated scale range is 0-100, with higher scores indicating more consistent medication adherence.
- Health-Related Quality of Life4, 8, and 12 month follow-ups
Health-related quality of life will be self-reported using the 31-item World Health Organization Quality of Life Brief Assessment for PLH (WHOQOL-HIV BREF). The calculated scale range is 0-100, with higher scores indicating better quality of life. Composite scores will be calculated in line with Walsh et al., 2024.
- Depressive Symptoms4, 8, and 12 month follow-ups
Depressive symptoms during the past 2 weeks will be self-reported via completion of the 9-item Patient Health Questionnaire-9 (PHQ-9). The calculated scale range is 0-27, with higher scores indicating more depressive symptoms.